1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2019

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the ‘Rete Ematologica Pugliese E Basilicata’

Mele, G., Pastore, D., Di Renzo, N., Fragasso, A., Guarini, A., Mazza, P., Musto, P., Pavone, V., Tarantini, G., Curci, P., Falcone, A. P., Mele, A., Miccolis, M. R., Palazzo, G., Palumbo, G., Quinto, A. M., Reddiconto, G., Rizzi, R., Cascavilla, N., Specchia, G. & 1 others, Capalbo, S. F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

2017

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

Lanza, F., Saraceni, F., Pezzi, A., Martino, M., Bosi, A., Cascavilla, N., Musto, P., Zuffa, E., Tani, M., Cellini, C., Laszlo, D., Bonifazi, F. & on behalf of GITMO (Italian Society for Transplantation), Sep 1 2017, In : American Journal of Hematology. 92, 9, p. E557-E559

Research output: Contribution to journalLetter